Pneumonia  >>  ciprofloxacin (Q3939)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ciprofloxacin (Q3939) / Bayer, Novartis
NCT01561794: A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia

Completed
3
44
Japan
Ciprofloxacin (Cipro, BAYQ3939)
Bayer
Pneumonia
03/15
03/15

Download Options